BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7605960)

  • 1. [MR mammography at 0.5 tesla. II. The capacity to differentiate malignant and benign lesions in MR mammography at 0.5 and 1.5 T].
    Kuhl CK; Kreft BP; Hauswirth A; Gieseke J; Elevelt A; Reiser M; Schild HH
    Rofo; 1995 Jun; 162(6):482-91. PubMed ID: 7605960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dynamic 3D MR mammography using a rapid gradient-echo sequence].
    Müller-Schimpfle M; Rieber A; Kurz S; Stern W; Claussen CD
    Rofo; 1995 Jan; 162(1):13-9. PubMed ID: 7841394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [MR mammography at 0.5 tesla. I. Comparison of image quality and sensitivity of MR mammography at 0.5 and 1.5 T].
    Kuhl CK; Kreft BP; Hauswirth A; Elevelt A; Steudel A; Reiser M; Schild HH
    Rofo; 1995 May; 162(5):381-9. PubMed ID: 7772759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MR mammography in patients at risk].
    Kaiser WA; Mittelmeier O
    Rofo; 1992 Jun; 156(6):576-81. PubMed ID: 1617179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A pharmacokinetic analysis of Gd-DTPA enhancement in MRT in breast carcinoma].
    Hess T; Knopp MV; Hoffmann U; Brix G; Junkermann H; Zuna I; von Fournier D; van Kaick G
    Rofo; 1994 Jun; 160(6):518-23. PubMed ID: 8011997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Magnetic resonance tomography of the breast. The results of 253 examinations].
    Kaiser WA
    Dtsch Med Wochenschr; 1989 Sep; 114(36):1351-7. PubMed ID: 2776660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The MRT of the breast with 2D-spin-echo and gradient-echo sequences in diagnostically problematic cases].
    Allgayer B; Lukas P; Loos W; Kersting-Sommerhoff B
    Rofo; 1993 May; 158(5):423-7. PubMed ID: 8490150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Technics for the preoperative marking of nonpalpable breast lesions in MRT].
    Sittek H; Kessler M; Müller-Lisse U; Untch M; Bohmert H; Reiser M
    Rofo; 1996 Jul; 165(1):84-7. PubMed ID: 8765369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique.
    Boetes C; Barentsz JO; Mus RD; van der Sluis RF; van Erning LJ; Hendriks JH; Holland R; Ruys SH
    Radiology; 1994 Dec; 193(3):777-81. PubMed ID: 7972823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quantitative dynamic contrast breast-MRI with the 0.5 tesla equipment].
    Klengel S; Hietschold V; Schreiber M; Köhler K
    Rontgenpraxis; 1994 Aug; 47(8):223-8. PubMed ID: 7974011
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dynamic imaging with magnetic resonance in the diagnosis of breast disease].
    Ercolani P; Giovagnoni A; Giuseppetti G; Baldassarre S; De Nigris E; Amici F
    Radiol Med; 1991 Oct; 82(4):422-6. PubMed ID: 1767046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gadolinium-DTPA (Magnevist) as contrast medium for galactography].
    Kaltenborn H; Schadmand S; Beck T; Thelen M
    Rofo; 1995 Nov; 163(5):457-9. PubMed ID: 8527765
    [No Abstract]   [Full Text] [Related]  

  • 13. [Contrast medium assisted dynamic MR-mammography after diagnostic and therapeutic interventions on the breast].
    Fischer U; Vosshenrich R; Kopka L; Kahlen O; Grabbe E
    Bildgebung; 1996 Jun; 63(2):94-100. PubMed ID: 8756151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contrast media in MR mammography].
    Tontsch P; Bauer M; Birmelin G; von Landenberg E; Moeller TB; Raible G
    Aktuelle Radiol; 1997 Mar; 7(2):86-92. PubMed ID: 9172669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast disease: tissue characterization with Gd-DTPA enhancement profiles.
    Stack JP; Redmond OM; Codd MB; Dervan PA; Ennis JT
    Radiology; 1990 Feb; 174(2):491-4. PubMed ID: 2296657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Subtraction and dynamic MR images of breast cancer].
    Murakami Y; Aoki M; Harada J
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Apr; 53(4):375-86. PubMed ID: 8493070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative 2- and 3-dimensional analysis of pharmacokinetic model-derived variables for breast lesions in dynamic, contrast-enhanced MR mammography.
    Hauth EA; Jaeger HJ; Maderwald S; Muehler A; Kimmig R; Forsting M
    Eur J Radiol; 2008 May; 66(2):300-8. PubMed ID: 17658235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Magnetic resonance tomography (MRT) of the breast in problem patients].
    Brezina A; Schwaighofer BW
    Wien Klin Wochenschr; 1994; 106(18):584-9. PubMed ID: 7992497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphology and contrast enhancement of ductal carcinoma in situ in dynamic 1.0 T MR mammography].
    Sittek H; Kessler M; Heuck AF; Bredl T; Perlet C; Künzer I; Lebeau A; Untch M; Reiser M
    Rofo; 1997 Sep; 167(3):247-51. PubMed ID: 9376552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ductal carcinoma in situ in dynamic MR-mammography at 1.5 T].
    Fischer U; Westerhof JP; Brinck U; Korabiowska M; Schauer A; Grabbe E
    Rofo; 1996 Apr; 164(4):290-4. PubMed ID: 8645861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.